Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tis⦠read more
Healthcare
Medical Instruments & Supplies
22 years
USD
Exclusive to Premium users
$0.49
Price-3.51%
-$0.01
$21.687m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$91.397m
-
1y CAGR-
3y CAGR-
5y CAGR-$58.051m
-
1y CAGR-
3y CAGR-
5y CAGR-$1.32
-
1y CAGR-
3y CAGR-
5y CAGR$14.835m
$79.801m
Assets$64.966m
Liabilities$44.607m
Debt55.9%
-1.1x
Debt to EBITDA$586k
-
1y CAGR-
3y CAGR-
5y CAGR